February 26, 2025

Results reflect resilience and ability to navigate the evolving aviation market successfully..
Metro Bank Holdings plc (LON:MRTO) is set to sell £584M in unsecured personal loans, enhancing balance sheet strategy and boosting capital ratios...
UJO is rapidly progressing with the installation of permanent production facilities, a move that underlines the strength of its US expansion strategy...
Hammerson plc declares a final cash dividend of 8.07p per share for the year ending December 2024, payable post-approval at the 2025 AGM...
Intermediate Capital Group plc appoints Robin Lawther as Non-Executive Director, effective 1 November 2025, enhancing their board with her vast financial expertise...
Hikma Pharmaceuticals reports strong 2024 results, with double-digit revenue growth, increased profits, and strategic acquisitions fueling optimism for 2025...
Convatec Group Plc reports robust FY24 results with double-digit growth in EPS and cash flow, driven by strategic execution and expanded product offerings...
The Group continues to demonstrate its growth trajectory with an increase in revenues for the year to 31 December 2024..
Another robust first half performance from the Advanced Engineering Systems (AES) division propelled the Group to record H1 revenues..
Indicated Resources are up 69% and now represent 83% of upgraded Resources allowing for Ore Reserve development..
Search

Funds

News

Results reflect resilience and ability to navigate the evolving aviation market successfully..
Metro Bank Holdings plc (LON:MRTO) is set to sell £584M in unsecured personal loans, enhancing balance sheet strategy and boosting capital ratios...
UJO is rapidly progressing with the installation of permanent production facilities, a move that underlines the strength of its US expansion strategy...
Hammerson plc declares a final cash dividend of 8.07p per share for the year ending December 2024, payable post-approval at the 2025 AGM...
Intermediate Capital Group plc appoints Robin Lawther as Non-Executive Director, effective 1 November 2025, enhancing their board with her vast financial expertise...
Hikma Pharmaceuticals reports strong 2024 results, with double-digit revenue growth, increased profits, and strategic acquisitions fueling optimism for 2025...
Convatec Group Plc reports robust FY24 results with double-digit growth in EPS and cash flow, driven by strategic execution and expanded product offerings...
The Group continues to demonstrate its growth trajectory with an increase in revenues for the year to 31 December 2024..
Another robust first half performance from the Advanced Engineering Systems (AES) division propelled the Group to record H1 revenues..
Indicated Resources are up 69% and now represent 83% of upgraded Resources allowing for Ore Reserve development..
Search

Funds

February 26, 2025

FTSE 100

Funds